Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BLUE BIOFUELS, INC. (ALLM)
|
Add to portfolio |
|
|
|
| Price: |
$0.35
| | Metrics |
| OS: |
301.1
|
M
| |
|
|
| Market cap: |
$105
|
M
| |
|
|
|
Net debt:
|
$504.9
|
k
| |
|
|
|
EV:
|
$106
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($3.2)
|
M
| |
|
|
|
EBIT
|
($3.4)
|
M
| |
|
|
| EPS |
($0.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 7.5 | 5.3 | 0.0 |
| Revenue growth | | | -100.0% | | -98.2% | 40.8% | | -100.0% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | -9.1 | 0.0 | 5.3 | -9.7 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.1 | 9.3 | 7.5 | 0.0 | 9.7 |
| Gross margin | | | | 100.0% | 6888.5% | 100.0% | 0.0% | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 2.4 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | | |
| General and administrative | 1.5 | 1.0 | 1.2 | 1.0 | 4.3 | 3.6 | 5.3 | 7.8 |
| EBITA | -3.9 | -2.2 | -2.0 | -1.8 | 0.5 | -1.5 | -5.2 | -5.9 |
| EBITA margin | | | | -2961.1% | 397.2% | -20.0% | -96.6% | |
| Amortization of intangibles | | | | | 0.3 | 0.6 | | |
| EBIT | -3.9 | -2.2 | -2.0 | -1.8 | 0.2 | -2.1 | -5.2 | -5.9 |
| EBIT margin | | | | -2961.1% | 152.4% | -27.8% | -96.6% | |
| Pre-tax income | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -8.8 | -4.8 | -9.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | 0.3 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.2% | | 0.0% |
| Earnings from continuing ops | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -9.5 | -5.8 | -9.9 |
| Earnings from discontinued ops | | | | | 0.0 | 1.2 | 0.7 | -1.9 |
| Net income | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -8.3 | -5.2 | -9.9 |
| Net margin | | | | 1675.2% | -7640.3% | -110.8% | -96.8% | |
| |
| Diluted EPS | ($0.01) | ($0.01) | ($0.01) | $0.01 | ($0.13) | ($0.16) | ($0.15) | ($0.27) |
| Shares outstanding (diluted) | 278.8 | 269.6 | 229.9 | 166.1 | 77.6 | 57.6 | 39.0 | 37.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|